Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SHE:002675)
China flag China · Delayed Price · Currency is CNY
13.45
+0.08 (0.60%)
Apr 28, 2026, 3:04 PM CST

SHE:002675 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
2,6522,7132,8463,2673,5653,897
Other Revenue
28.0528.0523.358.2418.3415.02
2,6812,7412,8693,2763,5833,912
Revenue Growth (YoY)
-7.84%-4.46%-12.42%-8.58%-8.41%14.42%
Cost of Revenue
1,2741,3561,5211,9222,0512,324
Gross Profit
1,4061,3851,3481,3541,5321,588
Selling, General & Admin
748.46745.12724.93754.41785.29802.41
Research & Development
230.61232.61291.91197.22163.52137.56
Other Operating Expenses
43.9740.7131.7633.8729.1933.34
Operating Expenses
1,0251,0331,065980.31980.56974.77
Operating Income
380.88352.17282.61373.77551.72612.99
Interest Expense
-146.28-137.54-96.51-56.76-58.64-56.45
Interest & Investment Income
6.975.175.5612.7813.25.12
Currency Exchange Gain (Loss)
-13.23-13.2315.4415.2542.65-4.08
Other Non Operating Income (Expenses)
-11.9-2.23-2.79-1.17-5.94-2.58
EBT Excluding Unusual Items
216.44204.34204.31343.86542.97555
Impairment of Goodwill
---52.6--80.1-211.26
Gain (Loss) on Sale of Investments
-14.44-15.88-12.92-28.13-39.21-12.15
Gain (Loss) on Sale of Assets
-0.31-0.330.21-0.23-0.38-0.15
Asset Writedown
---33.21---0.16
Other Unusual Items
23.323.3113.3121.7722.324.82
Pretax Income
225211.44219.1337.28445.58356.1
Income Tax Expense
52.845777.6883.0792.7595.25
Earnings From Continuing Operations
172.16154.44141.43254.22352.83260.85
Minority Interest in Earnings
32.1741.1942.4-44.48-45.54-109.29
Net Income
204.33195.63183.83209.74307.29151.56
Net Income to Common
204.33195.63183.83209.74307.29151.56
Net Income Growth
41.67%6.42%-12.35%-31.75%102.75%-63.72%
Shares Outstanding (Basic)
825825825825808802
Shares Outstanding (Diluted)
825825825825808802
Shares Change (YoY)
0.05%0.01%-0.01%2.10%0.68%0.01%
EPS (Basic)
0.250.240.220.250.380.19
EPS (Diluted)
0.250.240.220.250.380.19
EPS Growth
41.60%6.42%-12.35%-33.15%101.38%-63.73%
Free Cash Flow
73.13219.03-168.94-235606.93413.42
Free Cash Flow Per Share
0.090.27-0.20-0.280.750.52
Dividend Per Share
0.0810.0810.0800.1250.1500.150
Dividend Growth
0.78%0.78%-36.00%-16.67%--40.00%
Gross Margin
52.46%50.52%46.97%41.34%42.77%40.59%
Operating Margin
14.21%12.85%9.85%11.41%15.40%15.67%
Profit Margin
7.62%7.14%6.41%6.40%8.58%3.87%
Free Cash Flow Margin
2.73%7.99%-5.89%-7.17%16.94%10.57%
EBITDA
565.38530.64436.95511.69672.09727.92
EBITDA Margin
21.09%19.36%15.23%15.62%18.76%18.61%
D&A For EBITDA
184.51178.47154.34137.92120.37114.93
EBIT
380.88352.17282.61373.77551.72612.99
EBIT Margin
14.21%12.85%9.85%11.41%15.40%15.67%
Effective Tax Rate
23.48%26.96%35.45%24.63%20.82%26.75%
Revenue as Reported
2,6812,7412,8693,2763,5833,912
Advertising Expenses
-0.420.51.060.830.29
Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.